Hyloris Pharmaceuticals Statistics

Total Valuation

EBR:HYL has a market cap or net worth of EUR 149.52 million. The enterprise value is 136.86 million.

Market Cap	149.52M
Enterprise Value	136.86M

Important Dates

The next confirmed earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

EBR:HYL has 28.00 million shares outstanding. The number of shares has decreased by -1.65% in one year.

Current Share Class	28.00M
Shares Outstanding	28.00M
Shares Change (YoY)	-1.65%
Shares Change (QoQ)	+1.41%
Owned by Insiders (%)	58.91%
Owned by Institutions (%)	0.01%
Float	11.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.93
PB Ratio	5.65
P/TBV Ratio	7.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-21.61
EV / Sales	15.49
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.56

Financial Position

The company has a current ratio of 3.89, with a Debt / Equity ratio of 0.06.

Current Ratio	3.89
Quick Ratio	3.85
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.23
Interest Coverage	-10.43

Financial Efficiency

Return on equity (ROE) is -21.61% and return on invested capital (ROIC) is -15.53%.

Return on Equity (ROE)	-21.61%
Return on Assets (ROA)	-12.90%
Return on Invested Capital (ROIC)	-15.53%
Return on Capital Employed (ROCE)	-27.31%
Weighted Average Cost of Capital (WACC)	8.19%
Revenue Per Employee	176,660
Profits Per Employee	-126,680
Employee Count	50
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

Income Tax	-374,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.29% in the last 52 weeks. The beta is 0.66, so EBR:HYL's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	-14.29%
50-Day Moving Average	5.98
200-Day Moving Average	6.33
Relative Strength Index (RSI)	46.51
Average Volume (20 Days)	8,571

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EBR:HYL had revenue of EUR 8.83 million and -6.33 million in losses. Loss per share was -0.23.

Revenue	8.83M
Gross Profit	8.45M
Operating Income	-7.71M
Pretax Income	-6.71M
Net Income	-6.33M
EBITDA	-6.79M
EBIT	-7.71M
Loss Per Share	-0.23

Full Income Statement

Balance Sheet

The company has 14.27 million in cash and 1.61 million in debt, giving a net cash position of 12.66 million or 0.45 per share.

Cash & Cash Equivalents	14.27M
Total Debt	1.61M
Net Cash	12.66M
Net Cash Per Share	0.45
Equity (Book Value)	26.48M
Book Value Per Share	0.95
Working Capital	14.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.99 million and capital expenditures -4,000, giving a free cash flow of -7.00 million.

Operating Cash Flow	-6.99M
Capital Expenditures	-4,000
Depreciation & Amortization	919,000
Net Borrowing	-339,000
Free Cash Flow	-7.00M
FCF Per Share	-0.25

Full Cash Flow Statement

Margins

Gross margin is 95.71%, with operating and profit margins of -87.27% and -71.71%.

Gross Margin	95.71%
Operating Margin	-87.27%
Pretax Margin	-75.94%
Profit Margin	-71.71%
EBITDA Margin	-76.87%
EBIT Margin	-87.27%
FCF Margin	n/a

Dividends & Yields

EBR:HYL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.65%
Shareholder Yield	1.65%
Earnings Yield	-4.24%
FCF Yield	-4.68%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EBR:HYL has an Altman Z-Score of 10.75 and a Piotroski F-Score of 2.

Altman Z-Score	10.75
Piotroski F-Score	2